Deficiencies: In animals manganese deficiencies produce abnormalities in brain function, glucose tolerance, reproduction, and skeletal and cartilage formation. In humans, gross deficiencies have not been documented in free-living populations but deficiencies created in a metabolic unit suggest the mineral is important to maintain the integrity of the skin, bone and menstrual cycle, and in cholesterol metabolism. Certain population groups have been reported to have suboptimal status, including children with birth defects or on long-term total parenteral nutrition and patients with Perthes' disease, hip dislocations in Down's syndrome, osteoporosis, multiple sclerosis, non-trauma epilepsy, senile cataracts, acromegaly, and amyotrophic lateral sclerosis.
Diet recommendations: The Estimated Safe and Adequate Dietary Intakes (ESADDIs) for Mn each day are 2.0-5.0 mg for adults. For children, ESADDIs are 1.0-1.5 mg for ages 1-3 yrs; 1.5- 2.0 mg for ages 4-6 yrs, 2.0-3.0 mg for ages 7-10 yrs, and 2.0-5.0 for ages 11-14 yrs. Recent research suggest that recommendations for formula-fed infants are 0.005 mg/day and 0.030 mg/day for breast-fed infants.
Usual dietary intakes in the U.S. are about 2.2 and 2.8 mg/day for adult women and men, respectively. However, much higher intakes (10-18 mg) are found with vegetarian diets and those based on whole-grain products. Thus, the current ESADDI may be too conservative for adults.
Food sources: Excellent sources of manganese (>1 mg/serving) include pecans, peanuts, pineapple fruit and juice, oatmeal, shredded wheat and raisin bran cereal. Good sources (> 0.5 mg/serving) are beans (pinto, lima, navy), rice, spinach, sweet potato, and whole wheat bread. Very little Mn is found in meat, poultry, fish, milk, dairy products or sugary and refined foods.
Dietary components that may adversely affect manganese absorption, retention or excretion include iron, phosphorus, phytates, fiber, calcium, copper, and polyphenolic compounds.
Toxicity: Toxicity has occurred from industrial exposure, such as miners breathing manganese dust and drinking contaminated well water. Symptoms of toxicity are the development of a schizophrenia with nervous disorders resembling Parkinson's disease. The reference dose (RfD) set by the EPA in 1993 is 10 mg/day for a 70 kg body weight; this dietary level is considered to be without significant risk of a deleterious effect for a lifetime of exposure. There is no evidence of toxicity occurring from ingestion of typical diets. For drinking water, the RfD is 0.2 mg Mn/L.
Recent research: Lower manganese bloods levels have been observed in patients with osteoporosis, non-trauma epilepsy and Perthes' disease. Low dietary levels of manganese that lower the levels of Mn-superoxide dismutase may increase colon cancer susceptibility. Magnetic resonance imaging (MRI) is a very sensitive technique that can detect toxic accumulation of Mn in the brain.
For further information:
Freeland-Graves, J. H. & Turnlund, J.R. (1996) Deliberations and Evaluations of the Approaches, Endpoints and Paradigms for Manganese and Molybdenum Dietary Recommendations. J. Nutr. 126: 2435S-2440S.
Penland, J. & Johnson, P. (1993) Dietary manganese and calcium effects on menstrual cycle symptoms. Am. J. Obstet. Gynecol. 168: 1417-1423.
Prepared By:
Jeanne Freeland-Graves, Ph.D.
Bess Heflin Centennial Professor
and Head, Nutrition Division
Division of Nutrition A2700
University of Texas at Austin
Austin, TX 78712
Phone: 512-471-0657
FAX: 512-471-5844
Email: jfg@mail.utexas.edu
Phyllis Johnson, Ph.D.
Associate Director
USDA-ARS
Rm 233, Bldg 003, BARC-W
10300 Baltimore Avenue
Beltsville, MD 20705
Phone: 301-504-5193
FAX: 310-504-5863
Email: johnson@arx.usda.gov